Nursing protocol for the risk identification and prevention of Ovarian Hyperstimulation Syndrome (OHSS) in patients undergoing IVF treatment

被引：0
|
作者：
Figueiredo, T. [1 ]
Silva, L. [2 ]
Bonetti, T. [3 ]
Motta, E. [4 ]
Serafini, P. [5 ]
Panzan, M. [6 ]
Torelli, F. [6 ]
Assi, J. [2 ]
机构：
[1] Huntington Med Reprod, Nursing, Campinas, SP, Brazil
[2] Huntington Med Reprod, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Sci Gynecol Endocrinol Discipline, Gynecol Dept, Huntington Med Reprod, Sao Paulo, Brazil
[4] Univ Fed Sao Paulo, Gynecol Endocrinol Discipline, Gynecol Dept, Huntington Med Reprod, Sao Paulo, Brazil
[5] Univ Sao Paulo, Gynecol Discipline, Obstet & Gynecol Dept, Huntington Med Reprod, Sao Paulo, Brazil
[6] Huntington Med Reprod, Clin, Campinas, SP, Brazil
来源：
HUMAN REPRODUCTION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-540
引用
收藏
页码：382 / 383
页数：2
相关论文
共 50 条
  • [21] A cost comparison of "ganirelix salvage" protocol versus "coasting" strategy for patients at risk for ovarian hyperstimulation syndrome (OHSS).
    Wittenberger, MD
    Gustofson, RL
    Armstrong, A
    Segars, JH
    FERTILITY AND STERILITY, 2005, 84 : S318 - S318
  • [22] Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)
    Delvigne, A
    Rozenberg, S
    HUMAN REPRODUCTION UPDATE, 2003, 9 (01) : 77 - 96
  • [23] The usage of Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments
    Zhu, X.
    Fu, Y.
    HUMAN REPRODUCTION, 2016, 31 : 420 - 421
  • [24] Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
    Turan, Guluzar Arzu
    Eskicioglu, Fatma
    Sivrikoz, Oya Nermin
    Cengiz, Hakan
    Adakan, Saban
    Gur, Esra Bahar
    Tatar, Sumeyra
    Sahin, Nur
    Yilmaz, Osman
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 292 (05) : 1163 - 1171
  • [25] Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
    Guluzar Arzu Turan
    Fatma Eskicioglu
    Oya Nermin Sivrikoz
    Hakan Cengiz
    Saban Adakan
    Esra Bahar Gur
    Sumeyra Tatar
    Nur Sahin
    Osman Yilmaz
    Archives of Gynecology and Obstetrics, 2015, 292 : 1163 - 1171
  • [26] Role of Cabergoline in High Risk for Ovarian Hyper Stimulation Syndrome (OHSS) Prophylaxis Undergoing IVF/ICSI Treatment Cycles
    Bashir, Farukh
    Quratulain
    Choudhery, Khawar Abbas
    Hassan, Mujtaba
    Yasin, Imran
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2019, 13 (01): : 71 - 73
  • [27] Prevention and treatment of ovarian hyperstimulation syndrome
    Al-Shawaf, T
    Grudzinskas, JG
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2003, 17 (02) : 249 - 261
  • [28] Prevention and treatment of ovarian hyperstimulation syndrome
    Dourron, NE
    Williams, DB
    SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1996, 14 (04): : 355 - 365
  • [29] Prediction and prevention of ovarian hyperstimulation syndrome (OHSS) and the role of low molecular weight heparin (LMWH) in OHSS prevention and management
    ElPrince, M.
    Wang, F.
    Zhu, Y.
    Huang, H.
    HUMAN REPRODUCTION, 2012, 27
  • [30] From the pathophysiology and prevention of the ovarian hyperstimulation syndrome (OHSS) to therapy strategies -: An overview
    Kissler, S
    Siebzehnrübl, E
    Kaufmann, M
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2002, 62 (12) : 1155 - 1161
12345